Literature DB >> 15296093

In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines.

V Kettmann1, D Kosfálová, S Jantová, M Cernáková, J Drímal.   

Abstract

Previous studies on anti-cancer activity of protoberberine alkaloids against a variety of cancer cell lines were extended to human uterus HeLa nad murine leukemia L1210 cell lines. Cytotoxicity was measured using in vitro techniques and cell morphology changes were examined by light microscopy in both cytostatic and cytocidal concentration ranges. The IC50 was found to be less than 4 microg/ml, a limit put forward by NCI for classification of the compound as a potential anti-cancer drug. The microscopy examination indicated that at cytocidal concentrations the HeLa and L120 cells died apoptotically. The comparative analysis revealed that berberine belongs to the camptothecin family of drugs characterized by the ability to induce DNA topoisomerase poisoning and hence apoptotic cell death. Although the cytotoxic potency of berberine was found to be several orders of magnitude lower compared to camptothecin, its significance may increase in future in view of the lack of unwanted side effects characteristic for camptothecin compounds currently in clinical use for treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15296093

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  8 in total

1.  Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery.

Authors:  Sunil Kumar Battu; Michael A Repka; Sindhuri Maddineni; Amar G Chittiboyina; Mitchell A Avery; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

2.  Decrease in the production of β-amyloid by berberine inhibition of the expression of β-secretase in HEK293 cells.

Authors:  Feiqi Zhu; Fujun Wu; Ying Ma; Guangjian Liu; Zhong Li; Yong'an Sun; Zhong Pei
Journal:  BMC Neurosci       Date:  2011-12-12       Impact factor: 3.288

3.  Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity.

Authors:  Muhammad Umar Khayam Sahibzada; Abdul Sadiq; Hani S Faidah; Muhammad Khurram; Muhammad Usman Amin; Abdul Haseeb; Maria Kakar
Journal:  Drug Des Devel Ther       Date:  2018-02-14       Impact factor: 4.162

Review 4.  Berberine: a potential multipotent natural product to combat Alzheimer's disease.

Authors:  Hong-Fang Ji; Liang Shen
Journal:  Molecules       Date:  2011-08-09       Impact factor: 4.411

Review 5.  A Review of Antiplatelet Activity of Traditional Medicinal Herbs on Integrative Medicine Studies.

Authors:  Kyungho Kim; Kwang-Il Park
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-03       Impact factor: 2.629

6.  Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma.

Authors:  Lulu Ni; Ping Sun; Xiaochun Fan; Zhongjie Li; Hongli Ren; Jiangan Li
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

7.  An effective solution to discover synergistic drugs for anti-cerebral ischemia from traditional Chinese medicinal formulae.

Authors:  Shaojing Li; Chuanhong Wu; Jianxin Chen; Peng Lu; Chang Chen; Meihong Fu; Jing Fang; Jian Gao; Li Zhu; Rixin Liang; Xin Shen; Hongjun Yang
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

Review 8.  Biological Activity of Berberine-A Summary Update.

Authors:  Anna Och; Rafał Podgórski; Renata Nowak
Journal:  Toxins (Basel)       Date:  2020-11-12       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.